Transdermal drug delivery systems are simple to use and permit reliable administration of drugs [1] [2] [3] [4] [5] [6] . Fentanyl has been formulated into a transdermal therapeutic system (TTS-fentanyl, ALZA Corporation). In a previous study, we observed that plasma fentanyl concentrations during TTS-fentanyl therapy in patients undergoing upper abdominal surgery did not differ significantly from those in a matched group of patients receiving the same dose of fentanyl by i.v. infusion [7] . In the present study, we have investigated the efficacy of transdermal fentanyl as an analgesic regimen in patients undergoing upper abdominal surgery.
PATIENTS AND METHODS
After Ethics Committee approval and informed written patient consent, we studied 40 patients (ages 18-70 yr, weight 50-100 kg) undergoing elective upper abdominal surgery. None had clinical evidence of hepatic, respiratory, renal or psychiatric disease.
TTS-fentanyl is a rate-controlled drug delivery system which, in this study, was designed to deliver fentanyl 100 |ig rr 1 [7] . Patients were allocated randomly to receive TTS-fentanyl or TTS-placebo in this double-blind study. TTSplacebo was identical in design to TTS-fentanyl, except that the reservoir contained only normal DAVID J. ROWBOTHAM*, M.B., CH.B., M.R.C.P., F.F.A.R.C.S., saline. Two hours before surgery, the transdermal delivery system was placed on a hair-free area of the upper chest.
The anaesthetic regimen was the same in both groups. Anaesthesia was induced with thiopentone 5 mg kg" 1 and maintained with 0.5-2 % enflurane and 67 % nitrous oxide in oxygen. Fentanyl 200 ug was given at induction of anaesthesia. Neuromuscular block was achieved by vecuronium O.lmgkg" 1 at induction of anaesthesia and supplementary doses as required. The lungs were ventilated mechanically to maintain normocapnia. Neuromuscular block was antagonized with neostigmine 2.5 mg given with atropine 1.2 mg at the end of surgery.
Postoperative analgesia was standardized and administered by the Pharmacia Prominject programmable on-demand infusion pump [8] . The syringe contained a solution of morphine 4 mg ml" 1 in normal saline. Immediately after surgery, the Prominject was programmed to deliver an ondemand bolus dose of 2.5 mg with a lock-out time of 10 min. Ninety minutes later, the pump was reprogrammed to deliver a bolus of 1 mg with a lock-out time of 20 min. This regimen was discontinued 48 h after the application of the transdermal system.
Pain was assessed at 4, 8, 12 and 24 h after the application of the patch. Patients were asked to grade their pain by pointing at a large scale marked 0-9 (0 = no pain; 9 = worst pain imaginable). At these times, peak expiratory flow rates (PEFR) were measured using a Micromedics Pocket Spirometer [9] . All observations were made by one of two investigators.
Arterial blood samples for analysis of gas tensions were taken by radial artery puncture under local anaesthesia while the patient breathed air, at 0, 12 and 24 h. Venous blood also was taken at these times. Plasma was separated immediately and stored at -20 °C. Plasma fentanyl concentrations were measured subsequently by radioimmunoassay [10] .
Patients were withdrawn from the trial if the ventilatory rate decreased to less than 8 b.p.m. for more than 5 min. Nausea and vomiting were treated by prochlorperazine 12.5 mg i.m.
Data were analysed by Chi-square, MannWhitney or Student's t test as appropriate.
RESULTS
There were no significant differences between the groups with respect to age, sex, weight, duration and type of surgery (table I) . The TTS-fentanyl group demanded significantly less morphine 90 min after surgery (P < 0.01) and in the first 24 h (P < 0.01) (table II). Two patients in the placebo group demanded the maximum available amount of morphine 90 min after surgery (pain scores 7 and 9), but no patient demanded the maximum thereafter. Mean requirement for morphine was less also in the second 24 h, after the patch had been removed (P < 0.05). Median pain scores and ranges during the first 24 h (table III) were significantly less in the TTS-fentanyl group at each time interval. Mean PEFR at 12 h and at 24 h expressed as a percentage of the preoperative value (table IV) was significantly greater in the TTS-fentanyl group (P < 0.01 and P < 0.05, respectively). BRITISH JOURNAL OF ANAESTHESIA Arterial blood-gas tensions did not differ significantly (table V) , but mean rates of ventilation were lower (P < 0.05) in the TTS-fentanyl group at 12 and 24 h (table VI). No patient was withdrawn from the study because of low ventilatory rates.
Mean (SEM) plasma fentanyl concentrations in the TTS-fentanyl group at 12 and 24 h were 1.5 (0.1) and 2.0 (0.2) ng ml" 1 , respectively.
DISCUSSION
The TTS-fentanyl group demanded significantly less morphine in the first and second 24 h, but pain scores were consistently lower. Further evidence of improved analgesia in this group is shown by the greater PEFR. Rates of ventilation were lower in the TTS-fentanyl group at 12 and 24 h, but there were no differences in arterial blood-gas tensions. Although the placebo group demanded 33 % more morphine than the fentanyl group in the first 24 h, and had free access to morphine on demand, the quality of pain relief in the fentanyl group was significantly better. It is not clear why the placebo group did not demand more morphine. Greater analgesia in the TTS-fentanyl group may be explained by an inadequate on-demand morphine regimen, but this did not appear to be the case after the first 90 min of the study, as no patient demanded the maximum available dose of morphine. However, this probably was a factor during the immediate postoperative period, as two patients demanded the maximum available amount of morphine.
In a similar group of patients, the mean plasma half-life of fentanyl after removal of the patch was 15.7 h [7] . This is consistent with a depot of fentanyl remaining in the skin and may account for the fact that the TTS-fentanyl group demanded significantly less morphine in the 24 h after removal of the patch. The therapeutic range for plasma fentanyl concentration has been described as 1-3 ng ml"
1 [11] . At 12 and 24 h, mean fentanyl concentrations in the TTS-fentanyl group were within this range (1.5 and 2.0 ng ml" 1 ). Transdermal fentanyl resulted in better analgesia and PEFR associated with a reduction in morphine requirement after upper abdominal surgery. It may be useful in the management of postoperative pain. However, it seems likely that supplementary analgesia may be required in many patients if a system delivering fentanyl 100 (ig h" 1 is used. This was the maximum dose available at the time of the study.
In a previous study of similar design using fentanyl 100 ugh" 1 i.v. for upper abdominal surgery [12] , mean additional requirement for morphine was 19 (SEM 4) mg and pain was judged to be severe on 15% of occasions. Direct comparison with this study is difficult, as pain in that study was assessed on a four-point scale at 8, 12 and 24 h only. No assessment was made in the immediate postoperative period and morphine was given i.m. as required. Furthermore, our previous study has shown that plasma concentrations of fentanyl in the early postoperative period were significantly greater during i.v. infusion compared with transdermal adminis- tration when administration commenced 2 h before surgery [7] . TTS-fentanyl provides a significant degree of background analgesia and this, combined with ease of administration, may be an advantage.
